Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 6, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • A stronger COVID-19 mutant found

IIT Kanpur Life Science JRF Job-Opening | Applications Invited

Luminescence dating: a fascinating method

A stronger COVID-19 mutant found
  • BiotechToday
  • World

A stronger COVID-19 mutant found

bioxone December 29, 2020December 29, 2020

Husna, Amity University Kolkata

Just as the world was waiting with hope for the vaccine to start off a healthier 2021, UK has cautioned to take necessary precautionary measures against a new contagious COVID-19 mutant.

Scientists have stated that all viruses mutate as it’s in their nature to mutate, as the human body gets more proficient at identifying and fighting it, the virus is anticipated to fight back by trying to escape the body’s immune system.

Scientists have noted two distinct sets of mutations in the SARS-CoV-2 virus at the beginning of the pandemic, the H69/V70 deletion, and the D614G COVID-19 mutant. Recently, the new variant found in the U.K. is known as VUI – 202012/01 which is 70% more transmissible and infectious. Its mutations have occurred on the genetic material that controls the spike protein, which helps COVID and other similar viruses to bind to the human cell and infect it. So, the vaccines seek to target and weaken this ability of the virus.

Although there’s no evidence to date that this strain can cause a more intense illness or lead to a higher fatality rate but it’s faster transmission means more cases leading to a higher hospitalization rate. Moreover, there is no proof so far that the mutations can reduce the vaccine’s effectiveness.

Simon Clarke, an associate professor in cellular microbiology at the University of Reading, has stated that eventually, the covid-19 vaccine could require an updated version each year just like the flu-shot.

Also read: Moderna’s mRNA–1273 granted emergency use authorization by FDA

SOURCE:

https://www.hindustantimes.com/world-news/uk-hit-by-new-coronavirus-strain-here-s-a-look-at-other-mutations/storyzYo1syMagWYuIuou7Wr4qO.html

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged coronavirus latest update coronavirus precautions coronavirus second wave coronavirus uk COVID-19 fatality rate flu-shot illness immune system Mutation pandemic SARS-CoV-2 virus spike protein VACCINE vaccine news vaccine update virus

One thought on “A stronger COVID-19 mutant found”

  1. Pingback: Luminescence dating: a fascinating method - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Biotechnopedia
  • DNA-Tales

Luminescence dating: a fascinating method

bioxone December 29, 2020

Camelia Bhattacharyya, Amity University Kolkata Archaeology, anthropology, and the need to estimate dates: The study of humans and what made them where they are today is something of great interest and it has always been this way for ages. Knowledge of the past (history) leads to a better understanding of the present and the future. […]

Luminescence dating

Related Post

  • BiotechToday
  • World

Immune Surveillance in Multiple Sclerosis via T cells

bioxone September 20, 2020September 20, 2020

– Sagnik Nag, Amity University Kolkata Cerebrospinal fluid (CSF) protects the CNS from physical injuries as well as portrays immuno-surveillance over a pathogenic attack. In recent scientific research conducted by Pappalardo et al. profiled the T-cells present in the cerebrospinal fluid (CSF) of a healthy individual. It is known that T-cells ( be it CD4+ or […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • FEATURED
  • India
  • Latest
  • World

Does the neutrophil level detect the severity of COVID-19?

bioxone September 9, 2020September 9, 2020

–Sanket Roy, Team bioXone Hyperactivation of the immune system under SARS-CoV-2 infection is one of the most important features of COVID-19. While the early detection of COVID- 19 became the most emerging field of research, a team of scientists led by Hyung Chun of Yale University has identified that detection of neutrophil levels in plasma can indicate the […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • FEATURED
  • Latest
  • World

CAN LUNG CANCER MAKE YOU TEST POSITIVE FOR COVID-19?

bioxone September 10, 2020September 10, 2020

–Biswadeep Sen, Amity University Kolkata Lung Cancer is one of the most malignant tumors, making patients more susceptible to infections than normal individuals. Lung Cancer patients are susceptible to SARS-CoV-2 infection at a significantly higher rate than healthy individuals. Angiotensin-converting enzyme 2, acting as the COVID receptor, and the Transmembrane protease serine 2 acting as […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy